Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02869776 · ClinicalTrials.gov registry record · NA
Integrating HCV and HIV Screening During the Era of HIV Antigen Testing
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT02869776: Completed NA study, sponsored by Boston Medical Center.
NCT02869776 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02869776, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The objective of this proposal is to develop an optimal testing strategy for HCV and HIV in high prevalence settings, such as detoxification centers with a large proportion of young injection drug users. The latest venipuncture testing will be compared to rapid finger stick testing for HCV and HIV. Outcomes for each strategy among individuals admitted at a short-term drug detoxification center will be determined.
Primary Outcome
The number of participants who receive HCV test results by the time they are discharged from the detoxification center
Interventions
- PROCEDURE Venipuncture
- BEHAVIORAL Questionnaire
- PROCEDURE Rapid finger stick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-07-26 |
| Phase | NA |
What the finished NCT02869776 record still lists
NCT02869776 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 3 interventions - of which Venipuncture is the first listed.
NCT02869776 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02869776 about?
NCT02869776 is a clinical study titled "Integrating HCV and HIV Screening During the Era of HIV Antigen Testing". The objective of this proposal is to develop an optimal testing strategy for HCV and HIV in high prevalence settings, such as detoxification centers with a large proportion of young injection drug users. The latest venipuncture testing will be compared to rapid finger stick testing for HCV and HIV. ...
What is the current status of trial NCT02869776?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2016-09. Estimated completion is 2017-07-26.
What interventions are being tested in trial NCT02869776?
The interventions under investigation include: Venipuncture (PROCEDURE), Questionnaire (BEHAVIORAL), Rapid finger stick (PROCEDURE).
Who is sponsoring clinical trial NCT02869776?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02869776's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia